Higher Efficacy DMTs Reduce MS Brain Atrophy

BETHESDA, MD—How do disease-modifying therapies (DMTs) affect region-specific brain atrophy in multiple sclerosis? A recent study sought to answer that question. Researchers from the Center for Neuroscience and Regenerative Medicine, at The Henry M. Jackson Foundation...

TBI Might Not Be a Risk Factor for Alzheimer’s Disease

BOSTON—New research is calling into question whether traumatic brain injury is actually a risk factor for Alzheimer’s disease. A report in the journal Alzheimer’s & Dementia discussed recent research with neuropathologic or biomarker evidence of Alzheimer’s...

Many Survey Respondents Say Marijuana Is Good for MS

Despite insufficient evidence regarding its risks and benefits, marijuana is increasingly available and aggressively marketed to the public, according to a new study which sought to understand the public’s views on the risks and benefits of marijuana use.

Gene variant plus TBI worsens symptoms

A gene variant used to predict Alzheimer’s disease also appears to signal worse psychiatric symptoms in patients who have suffered a traumatic brain injury (TBI), a new study reported.